According to Pacific Biosciences 's latest financial reports the company's total debt is $0.93 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $0.93 B | -1.53% |
2022-12-31 | $0.94 B | -0.72% |
2021-12-31 | $0.95 B | 2174.71% |
2020-12-31 | $41.99 M | -31.9% |
2019-12-31 | $61.67 M | 320.71% |
2018-12-31 | $14.65 M | 7.51% |
2017-12-31 | $13.63 M | -15.34% |
2016-12-31 | $16.1 M | 7.75% |
2015-12-31 | $14.94 M | 6.84% |
2014-12-31 | $13.99 M | 4.83% |
2013-12-31 | $13.34 M | 379.07% |
2012-12-31 | $2.78 M | -4.78% |
2011-12-31 | $2.92 M | -3.65% |
2010-12-31 | $3.03 M | |
2009-12-31 | $N/A | -100% |
2008-12-31 | $1.3 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $34.91 B | 3,638.72% | ๐บ๐ธ USA |
General Electric GE | $22.93 B | 2,355.97% | ๐บ๐ธ USA |
Illumina ILMN | $2.26 B | 142.20% | ๐บ๐ธ USA |
PerkinElmer
PKI | $4.50 B | 382.88% | ๐บ๐ธ USA |
Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |
NanoString Technologies NSTG | $0.24 B | -73.48% | ๐บ๐ธ USA |